Stocktoria

Vericel Corp VCEL

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1997-02-04 · LEI

Vericel Corp institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.8,056,828$369.6M15.45%
TWO SIGMA INVESTMENTS, LP485,012$15.6M0.93%
D. E. Shaw & Co., Inc.295,626$9.5M0.57%
Point72 Asset Management, L.P.164,000$5.3M0.31%
CITADEL ADVISORS LLC113,546$3.7M0.22%
AQR CAPITAL MANAGEMENT LLC48,690$1.6M0.09%
MILLENNIUM MANAGEMENT LLC13,849$445,5220.03%
RENAISSANCE TECHNOLOGIES LLC12,600$405,3420.02%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.